The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Frequency of microsatellite instability (MSI) in upper tract urothelial carcinoma: comparison of the Bethesda panel and the Idylla MSI assay in a consecutively collected, multi-institutional cohort
Open accessAbstract
Aims: Upper tract urothelial carcinoma (UTUC) is a rare malignancy with a poor prognosis which occurs sporadically or in few cases results from a genetic disorder called Lynch syndrome. Recently, examination of microsatellite instability (MSI) has gained importance as a biomarker: MSI tumours are associated with a better response to immunomodulative therapies. Limited data are known about the prevalence of MSI in UTUC. New detection methods using the fully automated Idylla MSI Assay facilitate analysis of increased patient numbers. Methods: We investigated the frequency of MSI in a multi-institutional cohort of 243 consecutively collected UTUC samples using standard methodology (Bethesda panel), along with immunohistochemistry of mismatch repair (MMR) proteins. The same tumour cohort was retested using the Idylla MSI Assay by Biocartis. Results: Using standard methodology, 230/243 tumours were detected as microsatellite stable (MSS), 4/243 tumours as MSI and 9/243 samples as invalid. In comparison, the Idylla MSI Assay identified four additional tumours as MSS, equalling 234/243 tumours; 4/243 were classified as MSI and only 5/243 cases as invalid. At the immunohistochemical level, MSI results were supported in all available cases with a loss in MMR proteins. The overall concordance between the standard and the Idylla MSI Assay was 98.35%. Time to result differed between 3 hours for Idylla MSI Assay and 2 days with the standard methodology. Conclusion: Our data indicate a low incidence rate of MSI tumours in patients with UTUC. Furthermore, our findings highlight that Idylla MSI Assay can be applied as an alternative method of MSI analysis for UTUC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Deficiencies in MMR are detected using a consensus marker panel (Bethesda panel) and immunohistochemistry (IHC), although a more rapid PCR method using seven markers of MSI (Idylla MSI assay) appears promising [130].”
From Recent Advances in Therapeutic Strategies to Improve Colorectal Cancer Treatment (2024) · cites this paper as [130]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21551 · Cited by 20,160
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Microsatellite Instability in Colorectal Cancer
Boland, C. R., & Goel, A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.064 · Cited by 2,456
Ribic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022289 · Cited by 2,160
Humphrey, P. A., Moch, H., Cubilla, A. L., Ulbright, T. M., & Reuter, V. E. (2016) · European Urology · doi:10.1016/j.eururo.2016.02.028 · Cited by 1,916
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update
Rouprêt, M., Babjuk, M., Compérat, E., Zigeuner, R., Sylvester, R. J., Burger, M., Cowan, N. C., Gontero, P., Van Rhijn, B. W. G., Mostafid, A. H., et al. (2018) · European Urology · doi:10.1016/j.eururo.2017.07.036 · Cited by 1,514
Rouprêt, M., Babjuk, M., Compérat, E., Zigeuner, R., Sylvester, R. J., Burger, M., Cowan, N. C., Böhle, A., Van Rhijn, B. W. G., Kaasinen, E., et al. (2015) · European Urology · doi:10.1016/j.eururo.2015.06.044 · Cited by 1,341
Marcus, L., Lemery, S. J., Keegan, P., & Pazdur, R. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-4070 · Cited by 1,176 · cited 1×
“9 14 Currently, detection of MSI is mostly performed using the National Cancer Institute (NCI) consensus marker panel accompanied by immunohistochemistry analysis, which results in a time- to-diagnosis period of approximately two working days.”
Luchini, C., Bibeau, F., Ligtenberg, M. J. L., Singh, N., Nottegar, A., Bosse, T., Miller, R., Riaz, N., Douillard, J.-Y., Andre, F., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz116 · Cited by 1,041
Dietmaier, W., Wallinger, S., Bocker, T., Kullmann, F., Fishel, R. A., & Rüschoff, J. (1997) · PubMed · Cited by 742
Self-citation
Cited by
Recent Advances in Therapeutic Strategies to Improve Colorectal Cancer Treatment
Gmeiner, W. H. (2024) · Cancers · doi:10.3390/cancers16051029 · Cited by 78
“Deficiencies in MMR are detected using a consensus marker panel (Bethesda panel) and immunohistochemistry (IHC), although a more rapid PCR method using seven markers of MSI (Idylla MSI assay) appears promising [130].”
MethodKavun, A., Veselovsky, E., Lebedeva, A., Belova, E., Kuznetsova, O. A., Yakushina, V. D., Grigoreva, T. V., Mileyko, V., Fedyanin, M. Y., & Ivanov, M. V. (2023) · Cancers · doi:10.3390/cancers15082288 · Cited by 61
Chandran, E. B. A., Iannantuono, G. M., Atiq, S. O., Akbulut, D., Sinaii, N., Simon, N. I., Banday, A. R., Boudjadi, S., Gurram, S., Nassar, A. H., et al. (2024) · BMJ Oncology · doi:10.1136/bmjonc-2024-000335 · Cited by 28
Rasmussen, M., Madsen, M. G., & Therkildsen, C. (2022) · Urology · doi:10.1016/j.urology.2022.02.006 · Cited by 22
Upper tract urothelial carcinoma: epidemiology, presentation, and high-risk endemic populations
Clark, C. B., Matheny, M. V., & Raman, J. D. (2024) · Current Opinion in Urology · doi:10.1097/mou.0000000000001242 · Cited by 13
Metadata
- Authors
- Kullmann, F., Strissel, P. L., Strick, R., Stoehr, R., Eckstein, M., Bertz, S., Wullich, B., Sikic, D., Wach, S., Taubert, H., Olbert, P., Heers, H., Lara, M. F., Macias, M. L., Matas-Rico, E., Lozano, M. J., Prieto, D., Hierro, I., van Doeveren, T., Bieche, I., Masliah-Planchon, J., Beaurepere, R., Boormans, J. L., Allory, Y., Herrera-Imbroda, B., Hartmann, A., & Weyerer, V.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Brixsana Private Clinic (IT)
- Universitätsklinikum Gießen und Marburg (DE)
- Department of Urology, Virgen de la Victoria University Hospital Málaga, Instituto de Investigación Biomédica de Málaga, Málaga, Spain
- Genitourinary Cancer Translational Research Group, Instituto de Investigación Biomédica de Málaga, Málaga, Spain
- Instituto de Investigación Biomédica de Málaga (ES)
- Department of Pathology, Faculty of Medicine, Universidad de Málaga, Málaga, Spain
- Department of Pathology, Unidad de Gestión Clínica de Patología, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospital Universitario Virgen de la Victoria, Málaga, Spain
- Hospital Clínico Universitario Virgen de la Victoria (ES)
- Department of Urology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, Netherlands
- Department of Genetics, Institut Curie, PSL Research University, Paris, France
- Université Paris Sciences et Lettres (FR)
- Erasmus MC (NL)
- Department of Pathology, René Huguenin Curie Institute, Saint Cloud, Paris, France
- Corresponding author
- Weyerer, Veronika
- ORCID
- Venue
- Journal of Clinical Pathology
- Publisher
- BMJ
- Published
- 2021-09-28
- Volume
- 76
- Issue
- 2
- Pages
- 126-132
- ISSN
- 0021-9746 (ISSN-L)
- 1472-4146
- PMC
- PMC9887356
- OpenAlex
- W3204543246
- Cited by
- 20
- References
- 34
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 7 · 2023: 3 · 2022: 5
- FWCI
- 2.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Clinical Pathology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion, cc-by-nc)
- OPUS FAU (Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universitätsbibliothek Erlangen-Nürnberg) (submittedVersion, cc-by-nc)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion, other-oa)
- OPUS FAU (Kooperativer Bibliotheksverbund Berlin-Brandenburg (KOBV), on behalf of the Universitätsbibliothek Erlangen-Nürnberg) (cc-by)
- Funders
- Interdisciplinary Center for Clinical Research (IZKF) at the University Hospital of the Friedrich-Alexander University Erlangen-Nürnberg
- ERA-NET TRANSCAN
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Surgery › Bladder and Urothelial Cancer Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- upper tract urothelial carcinoma, microsatellite instability, mismatch repair proteins, Lynch syndrome, concordance
- MeSH terms
- Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Colorectal Neoplasms, Hereditary Nonpolyposis, Humans, Colorectal Neoplasms, Microsatellite Repeats, Microsatellite Instability, DNA Mismatch Repair
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Frequency of microsatellite instability (MSI) in upper tract urothelial carcinoma: comparison of the Bethesda panel and the Idylla MSI assay in a consecutively collected, multi-institutional cohort. https://app.cochat.ai/papers/10.1136/jclinpath-2021-207855
- The paper
- Kullmann, F., Strissel, P. L., Strick, R., Stoehr, R., Eckstein, M., Bertz, S., Wullich, B., Sikic, D., Wach, S., Taubert, H., Olbert, P., Heers, H., Lara, M. F., Macias, M. L., Matas-Rico, E., Lozano, M. J., Prieto, D., Hierro, I., van Doeveren, T., . . . Weyerer, V. (2023). Frequency of microsatellite instability (MSI) in upper tract urothelial carcinoma: comparison of the Bethesda panel and the Idylla MSI assay in a consecutively collected, multi-institutional cohort. Journal of Clinical Pathology. https://doi.org/10.1136/jclinpath-2021-207855
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.